Duluth hospitals offer COVID-19 treatment for those in early stages of symptoms, at risk of hospitalization

Physicians encourage those eligible to consider monoclonal antibody treatment in first 10 days of symptoms.
Written By: Andee Erickson
|
×
Buildings from Essentia Health-St. Mary's Medical Center (left) and St. Luke's hospital dominate this aerial view of Duluth's Central and East Hillside neighborhoods. (2017 file / News Tribune)
Duluth's two health care systems, Essentia Health and St. Luke's, are now weeks into offering monoclonal antibodies as a COVID-19 treatment for people with mild to moderate symptoms and at high risk of becoming hospitalized.
The U.S. Food and Drug Administration issued an emergency use authorization of the treatment in November. Shortly after, the federal government began distributing the treatment to states.

Related Keywords

Minnesota ,United States ,Duluth ,Virginia ,Deer River ,Stephanie Nixon ,Jonathan Shultz ,Amanda Noska ,Elisabeth Bilden ,Essentia Health In Duluth ,Essentia Health ,Drug Administration ,Minnesota Department Of Health ,Mary Medical Center ,Medical Center ,Minnesota Department ,மினசோட்டா ,ஒன்றுபட்டது மாநிலங்களில் ,துளுத் ,வர்ஜீனியா ,மான் நதி ,மாற்றாந்தாய் நிக்சன் ,ஜொனாதன் ஶ்யூல்ட்ஸ் ,எஸ்செந்திய ஆரோக்கியம் இல் துளுத் ,எஸ்செந்திய ஆரோக்கியம் ,மினசோட்டா துறை ஆஃப் ஆரோக்கியம் ,மேரி மருத்துவ மையம் ,மருத்துவ மையம் ,மினசோட்டா துறை ,